2014-2018 World E. Coli Testing Market: Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-- US, Europe (France, Germany, Italy, Spain, UK), Japan
The report contains 200 pages, 7 tables and presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the E. Coli definition, epidemiology and etiology are reviewed.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
- Role of Escherichia Coli in
- EPEC
- ETEC
- EIEC
- EHEC
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
- Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
- Immuno-PCR
- QC-PCR
- DAP-PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- Nucleic-Acid Sequence-Based
- Strand Displacement Activation
- Self-Sustained Sequence Replicase
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Dot Immunobinding Assays
- Capillary Immunoassays
- Particle-Membrane Capture Immunoassays
- Enzyme Amplification
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Chemiluminescence
- Bioluminescence
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus
LIST OF TABLES
France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Germany E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Italy E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Japan E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Spain E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Germany E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Italy E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Japan E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Spain E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment